These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
262 related articles for article (PubMed ID: 25933391)
1. Gene-wise association of variants in four lysosomal storage disorder genes in neuropathologically confirmed Lewy body disease. Clark LN; Chan R; Cheng R; Liu X; Park N; Parmalee N; Kisselev S; Cortes E; Torres PA; Pastores GM; Vonsattel JP; Alcalay R; Marder K; Honig LL; Fahn S; Mayeux R; Shelanski M; Di Paolo G; Lee JH PLoS One; 2015; 10(5):e0125204. PubMed ID: 25933391 [TBL] [Abstract][Full Text] [Related]
2. Association of glucocerebrosidase mutations with dementia with lewy bodies. Clark LN; Kartsaklis LA; Wolf Gilbert R; Dorado B; Ross BM; Kisselev S; Verbitsky M; Mejia-Santana H; Cote LJ; Andrews H; Vonsattel JP; Fahn S; Mayeux R; Honig LS; Marder K Arch Neurol; 2009 May; 66(5):578-83. PubMed ID: 19433657 [TBL] [Abstract][Full Text] [Related]
3. GBA mutations increase risk for Lewy body disease with and without Alzheimer disease pathology. Tsuang D; Leverenz JB; Lopez OL; Hamilton RL; Bennett DA; Schneider JA; Buchman AS; Larson EB; Crane PK; Kaye JA; Kramer P; Woltjer R; Kukull W; Nelson PT; Jicha GA; Neltner JH; Galasko D; Masliah E; Trojanowski JQ; Schellenberg GD; Yearout D; Huston H; Fritts-Penniman A; Mata IF; Wan JY; Edwards KL; Montine TJ; Zabetian CP Neurology; 2012 Nov; 79(19):1944-50. PubMed ID: 23035075 [TBL] [Abstract][Full Text] [Related]
4. Glucocerebrosidase mutations alter the endoplasmic reticulum and lysosomes in Lewy body disease. Kurzawa-Akanbi M; Hanson PS; Blain PG; Lett DJ; McKeith IG; Chinnery PF; Morris CM J Neurochem; 2012 Oct; 123(2):298-309. PubMed ID: 22803570 [TBL] [Abstract][Full Text] [Related]
5. Genetic modifiers of risk and age at onset in GBA associated Parkinson's disease and Lewy body dementia. Blauwendraat C; Reed X; Krohn L; Heilbron K; Bandres-Ciga S; Tan M; Gibbs JR; Hernandez DG; Kumaran R; Langston R; Bonet-Ponce L; Alcalay RN; Hassin-Baer S; Greenbaum L; Iwaki H; Leonard HL; Grenn FP; Ruskey JA; Sabir M; Ahmed S; Makarious MB; Pihlstrøm L; Toft M; van Hilten JJ; Marinus J; Schulte C; Brockmann K; Sharma M; Siitonen A; Majamaa K; Eerola-Rautio J; Tienari PJ; ; Pantelyat A; Hillis AE; Dawson TM; Rosenthal LS; Albert MS; Resnick SM; Ferrucci L; Morris CM; Pletnikova O; Troncoso J; Grosset D; Lesage S; Corvol JC; Brice A; Noyce AJ; Masliah E; Wood N; Hardy J; Shulman LM; Jankovic J; Shulman JM; Heutink P; Gasser T; Cannon P; Scholz SW; Morris H; Cookson MR; Nalls MA; Gan-Or Z; Singleton AB Brain; 2020 Jan; 143(1):234-248. PubMed ID: 31755958 [TBL] [Abstract][Full Text] [Related]
6. GBA Mutations Are Associated With Earlier Onset and Male Sex in Dementia With Lewy Bodies. Gámez-Valero A; Prada-Dacasa P; Santos C; Adame-Castillo C; Campdelacreu J; Reñé R; Gascón-Bayarri J; Ispierto L; Álvarez R; Ariza A; Beyer K Mov Disord; 2016 Jul; 31(7):1066-70. PubMed ID: 27027900 [TBL] [Abstract][Full Text] [Related]
7. The role of glucocerebrosidase mutations in Parkinson disease and Lewy body disorders. Velayati A; Yu WH; Sidransky E Curr Neurol Neurosci Rep; 2010 May; 10(3):190-8. PubMed ID: 20425034 [TBL] [Abstract][Full Text] [Related]
8. Characterization of Brain Lysosomal Activities in GBA-Related and Sporadic Parkinson's Disease and Dementia with Lewy Bodies. Moors TE; Paciotti S; Ingrassia A; Quadri M; Breedveld G; Tasegian A; Chiasserini D; Eusebi P; Duran-Pacheco G; Kremer T; Calabresi P; Bonifati V; Parnetti L; Beccari T; van de Berg WDJ Mol Neurobiol; 2019 Feb; 56(2):1344-1355. PubMed ID: 29948939 [TBL] [Abstract][Full Text] [Related]
9. Role of GBA variants in Lewy body disease neuropathology. Walton RL; Koga S; Beasley AI; White LJ; Griesacker T; Murray ME; Kasanuki K; Hou X; Fiesel FC; Springer W; Uitti RJ; Fields JA; Botha H; Ramanan VK; Kantarci K; Lowe VJ; Jack CR; Ertekin-Taner N; Savica R; Graff-Radford J; Petersen RC; Parisi JE; Reichard RR; Graff-Radford NR; Ferman TJ; Boeve BF; Wszolek ZK; Dickson DW; Ross OA; Heckman MG Acta Neuropathol; 2024 Mar; 147(1):54. PubMed ID: 38472443 [TBL] [Abstract][Full Text] [Related]
10. GBA variation and susceptibility to multiple system atrophy. Wernick AI; Walton RL; Koga S; Soto-Beasley AI; Heckman MG; Gan-Or Z; Ren Y; Rademakers R; Uitti RJ; Wszolek ZK; Cheshire WP; Dickson DW; Ross OA Parkinsonism Relat Disord; 2020 Aug; 77():64-69. PubMed ID: 32623306 [TBL] [Abstract][Full Text] [Related]
11. Role of Lysosomal Gene Variants in Modulating GBA-Associated Parkinson's Disease Risk. Straniero L; Rimoldi V; Monfrini E; Bonvegna S; Melistaccio G; Lake J; Soldà G; Aureli M; Shankaracharya ; Keagle P; Foroud T; Landers JE; Blauwendraat C; Zecchinelli A; Cilia R; Di Fonzo A; Pezzoli G; Duga S; Asselta R Mov Disord; 2022 Jun; 37(6):1202-1210. PubMed ID: 35262230 [TBL] [Abstract][Full Text] [Related]
12. Glucocerebrosidase gene variants are accumulated in idiopathic REM sleep behavior disorder. Gámez-Valero A; Iranzo A; Serradell M; Vilas D; Santamaria J; Gaig C; Álvarez R; Ariza A; Tolosa E; Beyer K Parkinsonism Relat Disord; 2018 May; 50():94-98. PubMed ID: 29487000 [TBL] [Abstract][Full Text] [Related]
13. Glucocerebrosidase deficiency in substantia nigra of parkinson disease brains. Gegg ME; Burke D; Heales SJ; Cooper JM; Hardy J; Wood NW; Schapira AH Ann Neurol; 2012 Sep; 72(3):455-63. PubMed ID: 23034917 [TBL] [Abstract][Full Text] [Related]
15. High Frequency of GBA Gene Mutations in Dementia With Lewy Bodies Among Ashkenazi Jews. Shiner T; Mirelman A; Gana Weisz M; Bar-Shira A; Ash E; Cialic R; Nevler N; Gurevich T; Bregman N; Orr-Urtreger A; Giladi N JAMA Neurol; 2016 Dec; 73(12):1448-1453. PubMed ID: 27723861 [TBL] [Abstract][Full Text] [Related]
16. Comprehensive short and long read sequencing analysis for the Gaucher and Parkinson's disease-associated GBA gene. Toffoli M; Chen X; Sedlazeck FJ; Lee CY; Mullin S; Higgins A; Koletsi S; Garcia-Segura ME; Sammler E; Scholz SW; Schapira AHV; Eberle MA; Proukakis C Commun Biol; 2022 Jul; 5(1):670. PubMed ID: 35794204 [TBL] [Abstract][Full Text] [Related]
17. Contribution of rare homozygous and compound heterozygous VPS13C missense mutations to dementia with Lewy bodies and Parkinson's disease. Smolders S; Philtjens S; Crosiers D; Sieben A; Hens E; Heeman B; Van Mossevelde S; Pals P; Asselbergh B; Dos Santos Dias R; Vermeiren Y; Vandenberghe R; Engelborghs S; De Deyn PP; Martin JJ; Cras P; Annaert W; Van Broeckhoven C; Acta Neuropathol Commun; 2021 Feb; 9(1):25. PubMed ID: 33579389 [TBL] [Abstract][Full Text] [Related]
18. Survival and dementia in GBA-associated Parkinson's disease: The mutation matters. Cilia R; Tunesi S; Marotta G; Cereda E; Siri C; Tesei S; Zecchinelli AL; Canesi M; Mariani CB; Meucci N; Sacilotto G; Zini M; Barichella M; Magnani C; Duga S; Asselta R; Soldà G; Seresini A; Seia M; Pezzoli G; Goldwurm S Ann Neurol; 2016 Nov; 80(5):662-673. PubMed ID: 27632223 [TBL] [Abstract][Full Text] [Related]
19. Association of ABI3 and PLCG2 missense variants with disease risk and neuropathology in Lewy body disease and progressive supranuclear palsy. Strickland SL; Morel H; Prusinski C; Allen M; Patel TA; Carrasquillo MM; Conway OJ; Lincoln SJ; Reddy JS; Nguyen T; Malphrus KG; Soto AI; Walton RL; Crook JE; Murray ME; Boeve BF; Petersen RC; Lucas JA; Ferman TJ; Uitti RJ; Wszolek ZK; Ross OA; Graff-Radford NR; Dickson DW; Ertekin-Taner N Acta Neuropathol Commun; 2020 Oct; 8(1):172. PubMed ID: 33092647 [TBL] [Abstract][Full Text] [Related]